Capecitabine and temozolomide (CAPTEM) in patients with advanced neuroendocrine tumors: The experience of a Portuguese cancer center

Category Primary study
JournalAnnals of Oncology
Year 2016
This article has no abstract
Epistemonikos ID: a9377ed4a8870f18addccb685f86a4ece6cf9259
First added on: Feb 08, 2025